Effect of different oil on serum lipids

Effect of different oil consumption on serum lipids in adults of Isfahan City

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT138905124497N1

Enrollment

200

Registered

2010-11-26

Start date

2006-09-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidemia. Hyperlipidemia

Interventions

Intervention 1: Unhydrogenated oil and Frying oil, Dosage: Calculating based on individual dietary pattern Period: 40 days Usage method: In diet. Intervention 2: Semihydrogenated oil (Free trans fatty

Prevention

Unhydrogenated oil and Frying oil, Dosage: Calculating based on individual dietary pattern Period: 40 days Usage method: In diet

Semihydrogenated oil (Free trans fatty acid), Dosage: Calculating based on individual dietary pattern Period: 40 days Usage method: In diet

Ghee oil, Dosage: Calculating based on individual dietary pattern Period: 40 days Usage method: In diet

Soft Margarine, Dosage: Calculating based on individual dietary pattern Period: 40 days Usage method: In diet

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Normal HTN, no diabetes, no cardiovascular diseases Exclusion criteria: TC=240mg/dl, TG=400mg/dl, LDL-C=160mg/dl, HDL-C=40mg/dl, body mass index (BMI) =35

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Total Cholesterol. Timepoint: Before and 40 days after the interventiondays. Method of measurement: Measurement (Autoanalyzer).;Triglyceride. Timepoint: Before and 40 days after the interventiondays. Method of measurement: Measurement (Autoanalyzer).;LDL. Timepoint: Before and 40 days after the interventiondays. Method of measurement: Calculating by Friedewald Formula.;HDL. Timepoint: Before and 40 days after the interventiondays. Method of measurement: Measurement (Autoanalyzer).;Apoprotein A. Timepoint: Before and 40 days after the interventiondays. Method of measurement: Measurement (Autoanalyzer).;Apoprotein B. Timepoint: Before and 40 days after the intervention. Method of measurement: Measurement (Autoanalyzer).	—

Measure

Time frame

Total Cholesterol. Timepoint: Before and 40 days after the interventiondays. Method of measurement: Measurement (Autoanalyzer).;Triglyceride. Timepoint: Before and 40 days after the interventiondays. Method of measurement: Measurement (Autoanalyzer).;LDL. Timepoint: Before and 40 days after the interventiondays. Method of measurement: Calculating by Friedewald Formula.;HDL. Timepoint: Before and 40 days after the interventiondays. Method of measurement: Measurement (Autoanalyzer).;Apoprotein A. Timepoint: Before and 40 days after the interventiondays. Method of measurement: Measurement (Autoanalyzer).;Apoprotein B. Timepoint: Before and 40 days after the intervention. Method of measurement: Measurement (Autoanalyzer).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNoushin Mohammadifard

Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences

mohammadifard@crc.mui.ac.irnmohammadifard@gmail.com+98 31 1337 7883

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026